1.Dowell P, Addy M: Dentine hypersensitivity—a review. Aetiology, symptoms and theories of pain production. J Clin Periodontol 1983, 10(4):341–350.
2.Canadian Advisory Board on Dentin H: Consensus-based recommendations for the diagnosis and management of dentin hypersensitivity. J Can Dent Assoc 2003, 69(4):221–226.
3.Brannstrom M, Astrom A: The hydrodynamics of the dentine; its possible relationship to dentinal pain. Int Dent J 1972, 22(2):219–227.
4.Absi EG, Addy M, Adams D: Dentine hypersensitivity. A study of the patency of dentinal tubules in sensitive and non-sensitive cervical dentine. J Clin Periodontol 1987, 14(5):280–284.
5.West NX: Dentine hypersensitivity: preventive and therapeutic approaches to treatment. Periodontol 2000 2008, 48:31–41.
6.Wong R, Hirsch RS, Clarke NG: Endodontic effects of root planing in humans. Endod Dent Traumatol 1989, 5(4):193–196.
7.Lin YH, Gillam DG: The Prevalence of Root Sensitivity following Periodontal Therapy: A Systematic Review. Int J Dent 2012, 2012:407023.
8.Pearce NX, Addy M, Newcombe RG: Dentine hypersensitivity: a clinical trial to compare 2 strontium densensitizing toothpastes with a conventional fluoride toothpaste. J Periodontol 1994, 65( 2):113–119.
9.Orchardson R, Gillam DG: The efficacy of potassium salts as agents for treating dentin hypersensitivity. J Orofac Pain 2000, 14(1):9–19.
10.Poulsen S, Errboe M, Lescay Mevil Y, Glenny AM: Potassium containing toothpastes for dentine hypersensitivity. Cochrane Database Syst Rev 2006(3):CD001476.
11.Suge T, Kawasaki A, Ishikawa K, Matsuo T, Ebisu S: Effects of pre- or post-application of calcium chloride on occluding ability of potassium oxalate for the treatment of dentin hypersensitivity. Am J Dent 2005, 18(2):121–125.
12.Ganss C, Klimek J, Schaffer U, Spall T: Effectiveness of two fluoridation measures on erosion progression in human enamel and dentine in vitro. Caries Res 2001, 35(5):325–330.
13.Tirapelli C, Panzeri H, Lara EH, Soares RG, Peitl O, Zanotto ED: The effect of a novel crystallised bioactive glass-ceramic powder on dentine hypersensitivity: a long-term clinical study. J Oral Rehabil 2011, 38(4):253–262.
14.Huang S, Gao S, Cheng L, Yu H: Remineralization potential of nano-hydroxyapatite on initial enamel lesions: an in vitro study. Caries Res 2011, 45(5):460–468.
15.Ma Q, Wang T, Meng Q, Xu X, Wu H, Xu D, Chen Y: Comparison of in vitro dentinal tubule occluding efficacy of two different methods using a nano-scaled bioactive glass-containing desensitising agent. J Dent 2017, 60:63–69.
16.Roveri N, Battistella E, Bianchi CL, Foltran I, Foresti E, Iafisco M, Lelli M, Naldoni A, Palazzo B, Rimondini L: Surface enamel remineralization: biomimetic apatite nanocrystals and fluoride ions different effects. J Nanomater 2009, 2009:8.
17.de Melo Alencar C, de Paula BLF, Guanipa Ortiz MI, Barauna Magno M, Martins Silva C, Cople Maia L: Clinical efficacy of nano-hydroxyapatite in dentin hypersensitivity: A systematic review and meta-analysis. J Dent 2019, 82:11–21.
18.Kim YS, Kwon HK, Kim BI: Effect of nano-carbonate apatite to prevent re-stain after dental bleaching in vitro. J Dent 2011, 39(9):636–642.
19.Lee SY, Kwon HK, Kim BI: Effect of dentinal tubule occlusion by dentifrice containing nano-carbonate apatite. J Oral Rehabil 2008, 35(11):847–853.
20.Lee SY, Jung HI, Jung BY, Cho YS, Kwon HK, Kim BI: Desensitizing efficacy of nano-carbonate apatite dentifrice and Er,Cr:YSGG laser: a randomized clinical trial. Photomed Laser Surg 2015, 33(1):9–14.
21.Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG, Consolidated Standards of Reporting Trials G: CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010, 63(8):e1–37.
22.Armitage GC: Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004, 34:9–21.
23.Tonetti MS, Claffey N, European Workshop in Periodontology group C: Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. J Clin Periodontol 2005, 32 Suppl 6:210–213.
24.Pepelassi E, Rahiotis C, Peponi E, Kakaboura A, Vrotsos I: Effectiveness of an in-office arginine-calcium carbonate paste on dentine hypersensitivity in periodontitis patients: a double-blind, randomized controlled trial. J Clin Periodontol 2015, 42(1):37–45.
25.Yilmaz HG, Kurtulmus-Yilmaz S, Cengiz E: Long-term effect of diode laser irradiation compared to sodium fluoride varnish in the treatment of dentine hypersensitivity in periodontal maintenance patients: a randomized controlled clinical study. Photomed Laser Surg 2011, 29(11):721–725.
26.Huskisson EC: Measurement of pain. Lancet 1974, 2(7889):1127–1131.
27.Schiff T, Dotson M, Cohen S, De Vizio W, McCool J, Volpe A: Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: a twelve-week clinical study. J Clin Dent 1994, 5 Spec No:87–92.
28.Neuhaus KW, Milleman JL, Milleman KR, Mongiello KA, Simonton TC, Clark CE, Proskin HM, Seemann R: Effectiveness of a calcium sodium phosphosilicate-containing prophylaxis paste in reducing dentine hypersensitivity immediately and 4 weeks after a single application: a double-blind randomized controlled trial. J Clin Periodontol 2013, 40(4):349–357.
29.Lin PY, Cheng YW, Chu CY, Chien KL, Lin CP, Tu YK: In-office treatment for dentin hypersensitivity: a systematic review and network meta-analysis. J Clin Periodontol 2013, 40(1):53–64.
30.Orsini G, Procaccini M, Manzoli L, Giuliodori F, Lorenzini A, Putignano A: A double-blind randomized-controlled trial comparing the desensitizing efficacy of a new dentifrice containing carbonate/hydroxyapatite nanocrystals and a sodium fluoride/potassium nitrate dentifrice. J Clin Periodontol 2010, 37(6):510–517.
31.Hirsiger C, Schmidlin PR, Michaelis M, Hirsch C, Attin T, Heumann C, Domejean S, Gernhardt CR: Efficacy of 8% arginine on dentin hypersensitivity: A multicenter clinical trial in 273 patients over 24 weeks. J Dent 2019, 83:1–6.
32.Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R: Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin Periodontol 1997, 24(11):808–813.
33.West NX, Seong J, Davies M: Management of dentine hypersensitivity: efficacy of professionally and self-administered agents. J Clin Periodontol 2015, 42 Suppl 16:S256–302.
34.He T, Chang J, Cheng R, Li X, Sun L, Biesbrock AR: Clinical evaluation of the fast onset and sustained sensitivity relief of a 0.454% stannous fluoride dentifrice compared to an 8.0% arginine-calcium carbonate-sodium monofluorophosphate dentifrice. Am J Dent 2011, 24(6):336–340.
35.Li Y, Lee S, Zhang YP, Delgado E, DeVizio W, Mateo LR: Comparison of clinical efficacy of three toothpastes in reducing dentin hypersensitivity. J Clin Dent 2011, 22(4):113–120.
36.Schiff T, Mateo LR, Delgado E, Cummins D, Zhang YP, DeVizio W: Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over. J Clin Dent 2011, 22(4):128–138.
37.West N, Newcombe RG, Hughes N, Mason S, Maggio B, Sufi F, Claydon N: A 3-day randomised clinical study investigating the efficacy of two toothpastes, designed to occlude dentine tubules, for the treatment of dentine hypersensitivity. J Dent 2013, 41(2):187–194.
38.Ayad F, Ayad N, Zhang YP, DeVizio W, Cummins D, Mateo LR: Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a commercial sensitive toothpaste containing 2% potassium ion: an eight-week clinical study on Canadian adults. J Clin Dent 2009, 20(1):10–16.
39.Nathoo S, Delgado E, Zhang YP, DeVizio W, Cummins D, Mateo LR: Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride relative to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in New Jersey, USA. J Clin Dent 2009, 20(4):123–130.
40.Chu CH, Lo EC: Immediate post-application effect of professional prophylaxis with 8% arginine-calcium carbonate desensitizing paste on hypersensitive teeth. A practitioner-based clinical trial. Am J Dent 2014, 27(1):7–11.
41.Elias Boneta AR, Galan Salas RM, Mateo LR, Stewart B, Mello S, Arvanitidou LS, Panagakos F, DeVizio W: Efficacy of a mouthwash containing 0.8% arginine, PVM/MA copolymer, pyrophosphates, and 0.05% sodium fluoride compared to a commercial mouthwash containing 2.4% potassium nitrate and 0.022% sodium fluoride and a control mouthwash containing 0.05% sodium fluoride on dentine hypersensitivity: a six-week randomized clinical study. J Dent 2013, 41 Suppl 1:S34–41.
42.Wara-aswapati N, Krongnawakul D, Jiraviboon D, Adulyanon S, Karimbux N, Pitiphat W: The effect of a new toothpaste containing potassium nitrate and triclosan on gingival health, plaque formation and dentine hypersensitivity. J Clin Periodontol 2005, 32(1):53–58.